{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2,4-dinitrochlorobenzene", "Wikstroemia dolichantha", "atopic dermatitis", "chamaejasmine", "interleukin 4", "skin barrier function"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31694198", "DateCompleted": {"Year": "2020", "Month": "08", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "05"}], "Language": ["eng"], "ELocationID": ["697", "10.3390/biom9110697"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "9", "Issue": "11", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "05"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Chamaejasmine Isolated from <i>Wikstroemia dolichantha</i> Diels Suppresses 2,4-Dinitrofluoro-benzene-Induced Atopic Dermatitis in SKH-1 Hairless Mice.", "Abstract": {"AbstractText": ["Plants of the genus <i>Wikstroemia</i> have long been used as traditional medicines to treat diseases like pneumonia, rheumatism, and bronchitis. This study was designed to determine the effect of chamaejasmine, a biflavonoid present in <i>W. dolichantha</i>, on atopic dermatitis (AD)-like skin lesions in a 2,4-dinitrochlorobenzene (DNCB)-induced murine model of AD. Initially, we examined the anti-allergic activities of ten flavonoids from <i>W. dolichantha</i> by measuring \u03b2-hexosaminidase release from RBL-2H3 cells. Subsequently, an SKH-1 hairless mouse model of AD was developed based on the topical application of DNCB. Chamaejasmine (0.5%) or pimecrolimus (1%, positive control) were applied to dorsal skins of DNCB-sensitized AD mice for two weeks. Serum IL-4 and IgE levels were determined using enzyme-linked immunosorbent assay kits and transepidermal water loss (TEWL) and skin hydration were measured using a Tewameter TM210 and a SKIN-O-MAT, respectively. Of the ten flavonoids isolated from <i>W. dolichantha</i>, chamaejasmine most potently inhibited DNP-specific IgE-induced degranulation in RBL-2H3 cells. Topical administration of chamaejasmine attenuated the clinical symptoms of DNCB-induced dermatitis (i.e., itching, dryness, erythema, and edema). Histological analyses demonstrated that dermal thickness and mast cell infiltration in dermis were significantly reduced by chamaejasmine. In addition, 0.5% chamaejasmine inhibited DNCB-induced increases in total IL-4 and IgE levels in serum, improved skin barrier function, and increased epidermis moisture. Our findings suggest chamaejasmine might be an effective therapeutic agent for the treatment of atopic diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Kim", "ForeName": "Tae-Young", "Initials": "TY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea."}], "LastName": "Park", "ForeName": "No-June", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Jegal", "ForeName": "Jonghwan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea."}], "LastName": "Choi", "ForeName": "Sangho", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea."}], "LastName": "Lee", "ForeName": "Sang Woo", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Kunming 650205, China."}], "LastName": "Hang", "ForeName": "Jin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea."}], "LastName": "Kim", "ForeName": "Su-Nam", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Yang", "ForeName": "Min Hye", "Initials": "MH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Allergic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biflavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Dinitrochlorobenzene"}, {"RegistryNumber": "0", "NameOfSubstance": "Il4 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "chamaejasmine"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}, {"RegistryNumber": "7KYV510875", "NameOfSubstance": "pimecrolimus"}, {"RegistryNumber": "EC 3.2.1.52", "NameOfSubstance": "beta-N-Acetylhexosaminidases"}, {"RegistryNumber": "WM0HAQ4WNM", "NameOfSubstance": "Tacrolimus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Topical"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Anti-Allergic Agents"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Biflavonoids"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dinitrochlorobenzene"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin E"}, {"QualifierName": ["blood"], "DescriptorName": "Interleukin-4"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "pharmacology"], "DescriptorName": "Tacrolimus"}, {"QualifierName": ["chemistry"], "DescriptorName": "Wikstroemia"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta-N-Acetylhexosaminidases"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Investig. 2004;113:651\u2013657. doi: 10.1172/JCI21060.", "ArticleIdList": ["10.1172/JCI21060", "PMC351324", "14991059"]}, {"Citation": "Chandra R.K., Lin D., Tan B., Tudor R.S., Conley D.B., Peters A.T., Grammer L.C., Schleimer R.P., Kern R.C. Chronic rhinosinusitis in the setting of other chronic inflammatory diseases. Am. J. Otolaryngol. 2011;32:388\u2013391. doi: 10.1016/j.amjoto.2010.07.013.", "ArticleIdList": ["10.1016/j.amjoto.2010.07.013", "PMC3387732", "20832903"]}, {"Citation": "Boccardi D., D\u2019Auria E., Turati F., DI M.V., Sortino S., Riva E., Cerri A. Disease severity and quality of life in children with atopic dermatitis: PO-SCORAD in clinical practice. Minerva Pediatr. 2017;69:373\u2013380.", "ArticleIdList": ["26200523"]}, {"Citation": "Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J. Dermatol. Sci. 2010;58:1\u20137. doi: 10.1016/j.jdermsci.2010.02.008.", "ArticleIdList": ["10.1016/j.jdermsci.2010.02.008", "20207111"]}, {"Citation": "Liu F.T., Goodarzi H., Chen H.Y. IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 2011;41:298\u2013310. doi: 10.1007/s12016-011-8252-4.", "ArticleIdList": ["10.1007/s12016-011-8252-4", "21249468"]}, {"Citation": "Kawakami T., Ando T., Kimura M., Wilson B.S., Kawakami Y. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 2009;21:666\u2013678. doi: 10.1016/j.coi.2009.09.006.", "ArticleIdList": ["10.1016/j.coi.2009.09.006", "PMC2839879", "19828304"]}, {"Citation": "Ma Q.Y., Chen Y.L., Huang S.Z., Kong F.D., Dai H.F., Hua Y., Zhao Y.X. Two New Lignans from Wikstroemia dolichantha. Chem. Nat. Compd. 2018;54:22\u201325. doi: 10.1007/s10600-018-2250-1.", "ArticleIdList": ["10.1007/s10600-018-2250-1"]}, {"Citation": "Guo J., Zhang J., Shu P., Kong L., Hao X., Xue Y., Luo Z., Li Y., Li G., Yao G., et al. Two new diterpenoids from the buds of Wikstroemia chamaedaphne. Molecules. 2012;17:6424\u20136433. doi: 10.3390/molecules17066424.", "ArticleIdList": ["10.3390/molecules17066424", "PMC6268896", "22643353"]}, {"Citation": "Chen Y., Fu W.W., Sun L.X., Wang Q., Qi W., Yu H. A new coumarin from Wikstroemia indica (l.) C.A. Mey. Chin. Chem. Lett. 2009;20:592\u2013594. doi: 10.1016/j.cclet.2009.01.002.", "ArticleIdList": ["10.1016/j.cclet.2009.01.002"]}, {"Citation": "Geng L.D., Zhang C., Xiao Y.Q. Studies on the chemical constituents in stem rind of Wikstroemia indica. Zhongguo Zhong Yao Za Zhi. 2006;31:817\u2013819.", "ArticleIdList": ["17048664"]}, {"Citation": "Li Y.M., Zhu L., Jiang J.G., Yang L., Wang D.Y. Bioactive components and pharmacological action of Wikstroemia indica (L.) CA Mey and its clinical application. Curr. Pharm. Biotechnol. 2009;10:743\u2013752. doi: 10.2174/138920109789978748.", "ArticleIdList": ["10.2174/138920109789978748", "19939213"]}, {"Citation": "Wang L.Y., Unehara T., Kitanaka S. Anti-inflammatory activity of new guaiane type sesquiterpene from Wikstroemia indica. Chem. Pharm. Bull. 2005;53:137\u2013139. doi: 10.1248/cpb.53.137.", "ArticleIdList": ["10.1248/cpb.53.137", "15635251"]}, {"Citation": "Jegal J., Park N.J., Kim T.Y., Choi S., Lee S.W., Hang J., Kim S.N., Yang M.H. Effect of topically applied Wikstroemia dolichantha Diels on the development of atopic dermatitis-like skin symptoms in mice. Nutrients. 2019;11:914. doi: 10.3390/nu11040914.", "ArticleIdList": ["10.3390/nu11040914", "PMC6521165", "31018627"]}, {"Citation": "Ragab E.A., Raafat M. A new monoterpene glucoside and complete assignments of dihydroflavonols of Pulicaria jaubertii: Potential cytotoxic and blood pressure lowering activity. Nat. Prod. Res. 2016;30:1280\u20131288. doi: 10.1080/14786419.2015.1055492.", "ArticleIdList": ["10.1080/14786419.2015.1055492", "26247309"]}, {"Citation": "Lee E.H., Kim H.J., Song Y.S., Jin C., Lee K.T., Cho J., Lee Y.S. Constituents of the stems and fruits of Opuntia ficus-indica var. saboten. Arch. Pharm. Res. 2003;26:1018\u20131023. doi: 10.1007/BF02994752.", "ArticleIdList": ["10.1007/BF02994752", "14723334"]}, {"Citation": "Fukui Y., Tanaka Y., Kusumi T., Iwashita T., Nomoto K. A rationale for the shift in colour towards blue in transgenic carnation flowers expressing the flavonoid 3\u2032,5\u2032-hydroxylase gene. Phytochemistry. 2003;63:15\u201323. doi: 10.1016/S0031-9422(02)00684-2.", "ArticleIdList": ["10.1016/S0031-9422(02)00684-2", "12657292"]}, {"Citation": "Chen L.Y., Chen I.S., Peng C.F. Structural elucidation and bioactivity of biflavonoids from the stems of Wikstroemia taiwanensis. Int. J. Mol. Sci. 2012;13:1029\u20131038. doi: 10.3390/ijms13011029.", "ArticleIdList": ["10.3390/ijms13011029", "PMC3269736", "22312302"]}, {"Citation": "Feng B., Pei Y., Hua H., Wang T., Zhang Y. Biflavonoids from Stellera chamaejasme. Pharm. Biol. 2003;41:59\u201361. doi: 10.1076/phbi.41.1.59.14701.", "ArticleIdList": ["10.1076/phbi.41.1.59.14701"]}, {"Citation": "Wan S.B., Chan T.H. Enantioselective synthesis of afzelechin and epiafzelechin. Tetrahedron. 2004;60:8207\u20138211. doi: 10.1016/j.tet.2004.06.113.", "ArticleIdList": ["10.1016/j.tet.2004.06.113"]}, {"Citation": "Davis A.L., Cai Y., Davies A.P., Lewis J.R. 1H and 13C NMR assignments of some green tea polyphenols. Magn. Reson. Chem. 1996;34:887\u2013890. doi: 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U.", "ArticleIdList": ["10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U"]}, {"Citation": "Kaur C., Kapoor H.C. Antioxidants in fruits and vegetables\u2013the millennium\u2019s health. Int. J. Food Sci. Technol. 2001;36:703\u2013725. doi: 10.1046/j.1365-2621.2001.00513.x.", "ArticleIdList": ["10.1046/j.1365-2621.2001.00513.x"]}, {"Citation": "Harborne J.B., Williams C.A. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481\u2013504. doi: 10.1016/S0031-9422(00)00235-1.", "ArticleIdList": ["10.1016/S0031-9422(00)00235-1", "11130659"]}, {"Citation": "Cook N.C., Samman S. Flavonoids\u2013chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996;7:66\u201376. doi: 10.1016/0955-2863(95)00168-9.", "ArticleIdList": ["10.1016/0955-2863(95)00168-9"]}, {"Citation": "Lien E.J., Ren S., Bui H.H., Wang R. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic. Biol. Med. 1999;26:285\u2013294. doi: 10.1016/S0891-5849(98)00190-7.", "ArticleIdList": ["10.1016/S0891-5849(98)00190-7", "9895218"]}, {"Citation": "Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002;13:572\u2013584. doi: 10.1016/S0955-2863(02)00208-5.", "ArticleIdList": ["10.1016/S0955-2863(02)00208-5", "12550068"]}, {"Citation": "Agati G., Azzarello E., Pollastri S., Tattini M. Flavonoids as antioxidants in plants: Location and functional significance. Plant Sci. 2012;196:67\u201376. doi: 10.1016/j.plantsci.2012.07.014.", "ArticleIdList": ["10.1016/j.plantsci.2012.07.014", "23017900"]}, {"Citation": "Kim H.P., Mani I., Iversen L., Ziboh V.A. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot. Essent. Fatty Acids. 1998;58:17\u201324. doi: 10.1016/S0952-3278(98)90125-9.", "ArticleIdList": ["10.1016/S0952-3278(98)90125-9", "9482162"]}, {"Citation": "Da Silva V.C., de Sousa P.T., Dall\u2019oglio E.L., Matiz G.E., de Carvalho M.G. Anti-inflammatory activities of flavonoids from Luxemburgia octandra flowers. Chem. Nat. Compd. 2011;46:961\u2013963. doi: 10.1007/s10600-011-9796-5.", "ArticleIdList": ["10.1007/s10600-011-9796-5"]}, {"Citation": "Kim H.P., Son K.H., Chang H.W., Kang S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci. 2004;96:229\u2013245. doi: 10.1254/jphs.CRJ04003X.", "ArticleIdList": ["10.1254/jphs.CRJ04003X", "15539763"]}, {"Citation": "Jin H., He R., Oyoshi M., Geha R.S. Animal models of atopic dermatitis. J. Investig. Dermatol. 2009;129:31\u201340. doi: 10.1038/jid.2008.106.", "ArticleIdList": ["10.1038/jid.2008.106", "PMC2886143", "19078986"]}, {"Citation": "Wolf R., Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin. Dermatol. 2012;30:329\u2013334. doi: 10.1016/j.clindermatol.2011.08.023.", "ArticleIdList": ["10.1016/j.clindermatol.2011.08.023", "22507048"]}, {"Citation": "Zhang E.Y., Chen A.Y., Zhu B.T. Mechanism of dinitrochlorobenzene-induced dermatitis in mice: Role of specific antibodies in pathogenesis. PLoS ONE. 2009;4:e7703. doi: 10.1371/journal.pone.0007703.", "ArticleIdList": ["10.1371/journal.pone.0007703", "PMC2766640", "19890385"]}, {"Citation": "Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., Duff G.W., Ward S.J., Tazi-Ahnini R. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene\u2013environment interactions. J. Allergy Clin. Immunol. 2006;118:3\u201321. doi: 10.1016/j.jaci.2006.04.042.", "ArticleIdList": ["10.1016/j.jaci.2006.04.042", "16815133"]}, {"Citation": "Kyselova Z. Toxicological aspects of the use of phenolic compounds in disease prevention. Interdiscip. Toxicol. 2011;4:173\u2013183. doi: 10.2478/v10102-011-0027-5.", "ArticleIdList": ["10.2478/v10102-011-0027-5", "PMC3274725", "22319251"]}, {"Citation": "Elias P.M., Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Allergy Clin. Immunol. 2009;9:437\u2013446.", "ArticleIdList": ["PMC2852024", "19550302"]}, {"Citation": "Middleton E. Flavonoids in the Living System. Springer; Boston, MA, USA: 1998. Effect of plant flavonoids on immune and inflammatory cell function; pp. 175\u2013182.", "ArticleIdList": ["9781303"]}, {"Citation": "Middleton E., Jr., Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 1992;43:1167\u20131179. doi: 10.1016/0006-2952(92)90489-6.", "ArticleIdList": ["10.1016/0006-2952(92)90489-6", "1562270"]}, {"Citation": "Cheong H., Ryu S.Y., Oak M.H., Cheon S.H., Yoo G.S., Kim K.M. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Arch. Pharm. Res. 1998;21:478\u2013480. doi: 10.1007/BF02974647.", "ArticleIdList": ["10.1007/BF02974647", "9875480"]}, {"Citation": "Mastuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M. Structural requirements of flavonoids for inhibition of antigen-induced degranulation, TNF-\u03b1 and IL-4 production from RBL-2H3 cells. Bioorg. Med. Chem. 2002;10:3123\u20133128. doi: 10.1016/S0968-0896(02)00227-4.", "ArticleIdList": ["10.1016/S0968-0896(02)00227-4", "12150856"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "15"}, {"Year": "2019", "Month": "10", "Day": "31"}, {"Year": "2019", "Month": "11", "Day": "1"}, {"Year": "2019", "Month": "11", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31694198", "PMC6921031", "10.3390/biom9110697", "biom9110697"]}}]}